Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 14, Pages 5689-5694
Publisher
Proceedings of the National Academy of Sciences
Online
2013-03-15
DOI
10.1073/pnas.1219457110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1
- (2012) Heli Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Basis for the Dual Recognition of Helical Cytokines IL-34 and CSF-1 by CSF-1R
- (2012) Xiaolei Ma et al. STRUCTURE
- Differential macrophage programming in the tumor microenvironment
- (2012) Brian Ruffell et al. TRENDS IN IMMUNOLOGY
- Mast cells in pancreatic ductal adenocarcinoma
- (2012) David Z. Chang OncoImmunology
- Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression
- (2011) Karl Staser et al. Annual Review of Pathology-Mechanisms of Disease
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bone metastasis: mechanisms and therapeutic opportunities
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells
- (2010) Suwen Wei et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
- (2010) G.-O. Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis
- (2010) Ricardo T Paniagua et al. ARTHRITIS RESEARCH & THERAPY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
- (2008) D. R. Artis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
- (2008) H. Lin et al. SCIENCE
- The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model
- (2007) Hiroaki Ohno et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now